Tenax Therapeutics Ownership | Who Owns Tenax Therapeutics?
Tenax Therapeutics Ownership Summary
Tenax Therapeutics is owned by 11.93% institutional investors, 0.15% insiders, and 87.92% retail investors. Ikarian capital is the largest institutional shareholder, holding 2.45% of TENX shares. TD Health Sciences - I is the top mutual fund, with 4.47% of its assets in Tenax Therapeutics shares.
TENX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tenax Therapeutics | 11.93% | 0.15% | 87.92% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ikarian capital | 967.60K | 2.45% | $7.36M |
| Vr adviser | 437.71K | 1.11% | $3.33M |
| Rtw investments, lp | 378.35K | 0.96% | $2.88M |
| Siren | 352.44K | 0.89% | $2.68M |
| Boothbay fund management | 352.21K | 0.89% | $2.68M |
| Bvf inc/il | 339.55K | 0.86% | $2.58M |
| Vivo capital | 208.33K | 0.53% | $1.59M |
| Morgan stanley | 178.33K | 0.45% | $1.36M |
| Marshall wace, llp | 177.21K | 0.45% | $1.35M |
| Integral health asset management | 167.00K | 0.42% | $1.27M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ikarian capital | 967.60K | 0.74% | $7.36M |
| Velan capital investment management lp | 83.33K | 0.60% | $634.16K |
| Vr adviser | 437.71K | 0.19% | $3.33M |
| Vivo capital | 208.33K | 0.13% | $1.59M |
| Siren | 352.44K | 0.10% | $2.68M |
| Bvf inc/il | 339.55K | 0.10% | $2.58M |
| Integral health asset management | 167.00K | 0.09% | $1.27M |
| Boothbay fund management | 352.21K | 0.04% | $2.68M |
| Adar1 capital management | 53.43K | 0.04% | $406.59K |
| Rtw investments, lp | 378.35K | 0.04% | $2.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ikarian capital | 967.60K | 0.74% | 967.60K |
| Siren | 352.44K | 0.10% | 352.44K |
| Boothbay fund management | 352.21K | 0.04% | 352.21K |
| Vr adviser | 437.71K | 0.19% | 339.14K |
| Marshall wace, llp | 177.21K | 0.00% | 177.21K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adar1 capital management | 53.43K | 0.04% | -102.13K |
| Dimensional fund advisors lp | - | - | -15.93K |
| Raymond james financial | - | - | -1.50K |
| Tower research capital llc (trc) | 501.00 | 0.00% | -748.00 |
| Rtw investments, lp | 378.35K | 0.04% | - |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 967.60K | 0.74% | 967.60K | $7.36M |
| Siren | 352.44K | 0.10% | 352.44K | $2.68M |
| Boothbay fund management | 352.21K | 0.04% | 352.21K | $2.68M |
| Marshall wace, llp | 177.21K | 0.00% | 177.21K | $1.35M |
| Woodline partners lp | 88.21K | 0.00% | 88.21K | $671.29K |
Sold Out
| Holder | Change |
|---|---|
| Raymond james financial | -1.50K |
| Dimensional fund advisors lp | -15.93K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 33 | 32.00% | 4,720,737 | 111.51% | 11 | 37.50% | 20 | 150.00% | 2 | -50.00% |
| Jun 30, 2025 | 25 | 8.70% | 2,231,961 | 11.24% | 5 | 18.75% | 8 | -11.11% | 4 | 33.33% |
| Mar 31, 2025 | 23 | 9.52% | 2,006,422 | 47.29% | 5 | 6.89% | 9 | - | 3 | - |
| Dec 31, 2024 | 21 | 10.53% | 1,362,190 | 10.84% | 8 | 26.45% | 9 | -43.75% | 3 | 200.00% |
| Sep 30, 2024 | 19 | 90.00% | 1,228,920 | 6426.74% | 5 | 73334.16% | 16 | 220.00% | 1 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| TD Health Sciences - I | 177.30K | 4.47% | - |
| Vanguard Total Stock Mkt Idx Inv | 96.16K | 2.32% | 96.16K |
| T. Rowe Price Health Sciences | 21.18K | 0.62% | -89.13K |
| Vanguard Institutional Extnd Mkt Idx Tr | 24.09K | 0.58% | 1.80K |
| Fidelity Extended Market Index | 17.93K | 0.39% | -147.00 |
| DFA US Targeted Value I | 13.39K | 0.29% | - |
| T. Rowe Price Health Sciences Port | 5.36K | 0.16% | 5.36K |
| Fidelity Total Market Index | 5.97K | 0.13% | - |
| NT Ext Equity Mkt Idx Fd - NL | 4.59K | 0.11% | - |
| Fidelity Series Total Market Index | 4.86K | 0.11% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 18, 2025 | Giordano Christopher Thomas | CEO | Buy | $12.50K |
| Nov 20, 2025 | Giordano Christopher Thomas | CEO | Buy | $4.08K |
| Nov 19, 2025 | Giordano Christopher Thomas | CEO | Buy | $3.42K |
| Nov 17, 2025 | MCGAULEY THOMAS | Interim CFO | Buy | $14.67K |
| Nov 17, 2025 | MCGAULEY THOMAS | Interim CFO | Buy | $36.14K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 8 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
TENX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools